Cancer Prevention

The trial will be available for just 44 patients around the world. After the trial finishes, the vaccine will either be licensed for use or if it's successful, a bigger study will be carried out

The Karnataka government on Thursday signed a memorandum of understanding (MoU) with AstraZeneca Pharma India Ltd., to deploy Artificial Intelligence (AI) based lung cancer screening technology that will screen a patient for 29 lung diseases in one chest X-ray. This AI-powered chest X-ray system developed by healthtech startup 'Qure.ai' will help the government detect lung nodules, often precursors to lung cancer, in 19 district hospitals in Karnataka, overcoming a major early detection challenge, officials said. The MoU was inked by National Health Mission, Health & Family Welfare Services, on behalf of the government, in the presence of Health Minister Dinesh Gundu Rao. Cancer can be treated with curative intent if detected early. We are bringing this technology in all our district hospitals across Karnataka, and we strongly believe that this will emerge as the most beneficial way of detecting lung cancer early and bringing down the financial and emotional burden of healthcare ..

Cancer screenings and treatment were affected due to Covid but the screening services have gone up post-pandemic, Union Minister of State for Health Bharti Pawar informed Lok Sabha on Friday. Replying to a supplementary question in the Lok Sabha during Question Hour, she said the government is focusing on increasing screenings and early detection of cancer. "Due to Covid, cancer screenings and treatment were affected. After Covid, screenings have increased," Pawar said. She said cancer screening services are being provided through 1.5 lakh Health and Wellness Centres (HWC) across the country. Through these HWCs, 16 crore cases of oral cancer, eight crore cases of breast cancer and around 5.53 crore cases of cervical cancer have been detected, the minister said. "Whether it is rural or urban areas, these services need to be increased. In that view, we are going to increase our 1.5 lakh HWCs throughout the country and through that, we are providing very good screening services," she

Citing results of a study published in an American science journal, JCO Global Oncology, it said cancer rates are rising rapidly across India

Company's solution has been used to conduct over 43,000 screenings in India so far. Niramai's breast cancer test comes at a 20th of the cost of a typical mammography test and detects 20% more cases

Natco Pharma said its marketing partner Breckenridge Pharmaceutical received final approval from the USFDA for Pomalidomide Capsules, treatment of patients suffering from multiple myeloma cancer

When exposed to radiation, more elephant cells than human cells underwent programmed cell death